495 related articles for article (PubMed ID: 18853647)
1. [Vancomycin resistance among strains of Enterococcus faecium].
Sacha P; Wieczorek P; Jakoniuk P
Przegl Lek; 2008; 65(5):229-32. PubMed ID: 18853647
[TBL] [Abstract][Full Text] [Related]
2. [Drug resistance of 100 clinical strains of Enterococcus spp].
Sawicka-Grzelak A; Rokosz A; Luczak M
Med Dosw Mikrobiol; 1999; 51(3-4):239-47. PubMed ID: 10803253
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of vancomycin-resistant enterococci in relation to the administration of glycopeptide antibiotics.
Kolár M; Vágnerová I; Látal T; Kohnová I
Acta Univ Palacki Olomuc Fac Med; 1999; 142():69-71. PubMed ID: 10743728
[TBL] [Abstract][Full Text] [Related]
4. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
5. Selection of a teicoplanin-resistant Enterococcus faecium mutant during an outbreak caused by vancomycin-resistant enterococci with the vanB phenotype.
Kawalec M; Gniadkowski M; Kedzierska J; Skotnicki A; Fiett J; Hryniewicz W
J Clin Microbiol; 2001 Dec; 39(12):4274-82. PubMed ID: 11724832
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype.
Song JH; Ko KS; Suh JY; Oh WS; Kang CI; Chung DR; Peck KR; Lee NY; Lee WG
J Antimicrob Chemother; 2008 Apr; 61(4):838-44. PubMed ID: 18230690
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of phenotypic and genotypic characteristics of vancomycin-resistant Enterococcus faecium isolates].
Aktaş Z; Diyarbakirli P; Bal C; Gürler N; Keser M; Somer A; Salman N
Mikrobiyol Bul; 2007 Jul; 41(3):347-56. PubMed ID: 17933244
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the MicroScan system and the agar dilution assay for Quinupristin/Dalfopristin susceptibility of Enterococcus faecium.
Kim YR; Kim SI; Hur JA; Kim YJ; Wie SH; Park YJ; Kang MW
Ann Clin Lab Sci; 2007; 37(3):260-2. PubMed ID: 17709691
[TBL] [Abstract][Full Text] [Related]
10. High incidence of vancomycin resistance in Enterococcus faecalis strains in a French hospital.
Garnier F; Ducancelle A; Boisset S; Pineiro A; Bergeret M; Denis F; Raymond J
Int J Antimicrob Agents; 2004 May; 23(5):529-30. PubMed ID: 15120739
[No Abstract] [Full Text] [Related]
11. Emergence of VanD-type vancomycin-resistant Enterococcus faecium in Stockholm, Sweden.
Fang H; Hedin G; Telander B; Li G; Nord CE
Clin Microbiol Infect; 2007 Jan; 13(1):106-8. PubMed ID: 17184299
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of quinupristin/dalfopristin and other antibiotics against ampicillin-resistant enterococcus faecium.
Wang FD; Liu IM; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):119-23. PubMed ID: 10677922
[TBL] [Abstract][Full Text] [Related]
13. Trimethoprim resistance genes in vancomycin-resistant Enterococcus faecium clinical isolates from France.
Cattoir V; Huynh TM; Bourdon N; Auzou M; Leclercq R
Int J Antimicrob Agents; 2009 Oct; 34(4):390-2. PubMed ID: 19619988
[No Abstract] [Full Text] [Related]
14. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
Vouillamoz J; Moreillon P; Giddey M; Entenza JM
J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
[TBL] [Abstract][Full Text] [Related]
15. [Molecular characterization of vancomycin-resistant enterococci isolates].
Liu YM; Cao B; Wang H; Li BB; Yang CX; Wang QT; Du XL; Li F; Wang SS; Qu SS
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):760-3. PubMed ID: 18683685
[TBL] [Abstract][Full Text] [Related]
16. Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilities.
Babalola CP; Patel KB; Nightingale CH; Nicolau DP
Int J Antimicrob Agents; 2004 Apr; 23(4):343-8. PubMed ID: 15081082
[TBL] [Abstract][Full Text] [Related]
17. [In vitro susceptibility of Enterococcus strains to high level aminoglycosides and heavy metals].
Nakipoğlu Y; Gümüş D; Sertel Selale D; Küçüker MA
Mikrobiyol Bul; 2009 Oct; 43(4):545-51. PubMed ID: 20084907
[TBL] [Abstract][Full Text] [Related]
18. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
Drago L; Nicola L; De Vecchi E
Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of vancomycin-susceptible and -resistant enterococci isolated in Italy from raw meat products, farm animals, and human infections.
Busani L; Del Grosso M; Paladini C; Graziani C; Pantosti A; Biavasco F; Caprioli A
Int J Food Microbiol; 2004 Dec; 97(1):17-22. PubMed ID: 15527914
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and genotypic differences of the vancomycin-resistant Enterococcus faecium isolates from humans and poultry in Korea.
Oh JY; An S; Jin JS; Lee YC; Cho DT; Lee JC
J Microbiol; 2007 Oct; 45(5):466-72. PubMed ID: 17978808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]